{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:16:04Z","timestamp":1759774564073},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s31628","type":"journal-article","created":{"date-parts":[[2012,9,16]],"date-time":"2012-09-16T23:48:41Z","timestamp":1347839321000},"page":"235","source":"Crossref","is-referenced-by-count":10,"title":["Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension"],"prefix":"10.2147","author":[{"given":"Olivier","family":"Lambert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Bandilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,9]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=13979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:25:57Z","timestamp":1477851957000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/stability-and-preservation-of-a-new-formulation-of-epoprostenol-sodium-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s31628","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}